Connolly Joan 4
4 · enGene Holdings Inc. · Filed Feb 3, 2026
Research Summary
AI-generated summary of this filing
enGene (ENGN) CTO Joan Connolly Receives 195,000-Share Option Award
What Happened
Joan Connolly, Chief Technology Officer of enGene Holdings, was granted a derivative award (an option) covering 195,000 shares on January 30, 2026. The reported acquisition price is $0.00, meaning no cash was paid at grant. This is a grant/award for compensation purposes rather than an open-market purchase or sale.
Key Details
- Transaction date: 2026-01-30; Form 4 filed 2026-02-03 (timely filing).
- Security: Derivative (option) for 195,000 shares; reported acquisition price $0.00.
- Vesting: Option vests monthly in substantially equal amounts over 48 months, subject to continued service (per footnote).
- Shares owned after transaction: Not reported in this filing.
- Transaction code: A = Award/Grant.
Context
Option grants are common executive compensation and are intended to align management incentives with shareholder value over time. Because this is a vesting award (not an immediate purchase or sale), it does not reflect an immediate market buy/sell decision; value is realized only as options vest and — if exercised — shares are acquired.
Insider Transaction Report
- Award
Stock Option (Right to Buy)
[F1]2026-01-30+195,000→ 195,000 totalExercise: $9.53Exp: 2036-01-30→ Common Shares (195,000 underlying)
Footnotes (1)
- [F1]This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service.